 | • レポートコード：QYR9ST01013 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のIDO阻害剤市場について調査・分析し、以下の構成でお届け致します。IDO阻害剤の種類別には、デュアルIDO1 / TDO阻害剤、共有結合IDO阻害剤に、用途別には、転移性黒色腫、転移性膵臓癌、mCRPC、悪性神経膠腫、星状細胞腫、乳癌に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別IDO阻害剤売上データ ・地域別IDO阻害剤市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別IDO阻害剤市場規模：デュアルIDO1 / TDO阻害剤、共有結合IDO阻害剤 ・用途別IDO阻害剤市場規模：転移性黒色腫、転移性膵臓癌、mCRPC、悪性神経膠腫、星状細胞腫、乳癌 ・主要メーカーの企業情報：Pfizer、Bristol-Myers Squibb、Kyowa Hakko Kirin ・IDO阻害剤の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
The IDO (indoleamine 2,3-dioxygenase 1, IDO1, IDO-1, INDO, indoleamine-pyrrole 2,3-dioxygenase) inhibitors pipeline analysis report includes ongoing clinical and non-clinical trends in the global IDO inhibitors market. Most of the pipeline therapeutics are in early stage of development, the market is yet to witness first IDO inhibitor launch and its impact on overall oncology market.Indoleamine-2,3-dioxygenase (IDO) is one of the many immune checkpoints in tumor immune escape. Inhibiting IDO will help researchers restore immune system responses, which in turn, will help identify and destroy cancer cells. In addition to transforming the approach to treat advanced melanoma, the successful entry of IDO inhibitors in the market will also help transform the treatment of non-small lung cancer, triple-negative breast cancer, and bladder cancer with the existing therapies. Currently, most of the IDO inhibitors under investigation are in the very nascent development stage and focusing on R&D, pharmaceutical companies are making huge investments through collaboration agreements. For instance, one of the major pharmaceutical companies Pfizer has partnered with iTeos Therapeutics for the development of undisclosed IDO1 and tryptophan 2,3-dioxygenase 2 (TDO2) inhibitors.
The global IDO Inhibitors market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the IDO Inhibitors market based on company, product type, end user and key regions.
This report studies the global market size of IDO Inhibitors in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of IDO Inhibitors in these regions.
This research report categorizes the global IDO Inhibitors market by top players/brands, region, type and end user. This report also studies the global IDO Inhibitors market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Bristol-Myers Squibb
Kyowa Hakko Kirin
Market size by Product
Dual IDO1/TDO inhibitors
Covalent IDO inhibitors
Market size by End User
Metastatic Melanoma
Metastatic Pancreatic Cancer
mCRPC
Malignant Glioma
Astrocytoma
Breast Cancer
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global IDO Inhibitors market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of IDO Inhibitors market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global IDO Inhibitors companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of IDO Inhibitors submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of IDO Inhibitors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of IDO Inhibitors market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 IDO Inhibitors Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global IDO Inhibitors Market Size Growth Rate by Product
1.4.2 Dual IDO1/TDO inhibitors
1.4.3 Covalent IDO inhibitors
1.5 Market by End User
1.5.1 Global IDO Inhibitors Market Size Growth Rate by End User
1.5.2 Metastatic Melanoma
1.5.3 Metastatic Pancreatic Cancer
1.5.4 mCRPC
1.5.5 Malignant Glioma
1.5.6 Astrocytoma
1.5.7 Breast Cancer
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global IDO Inhibitors Market Size
2.1.1 Global IDO Inhibitors Revenue 2014-2025
2.1.2 Global IDO Inhibitors Sales 2014-2025
2.2 IDO Inhibitors Growth Rate by Regions
2.2.1 Global IDO Inhibitors Sales by Regions
2.2.2 Global IDO Inhibitors Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 IDO Inhibitors Sales by Manufacturers
3.1.1 IDO Inhibitors Sales by Manufacturers
3.1.2 IDO Inhibitors Sales Market Share by Manufacturers
3.1.3 Global IDO Inhibitors Market Concentration Ratio (CR5 and HHI)
3.2 IDO Inhibitors Revenue by Manufacturers
3.2.1 IDO Inhibitors Revenue by Manufacturers (2014-2019)
3.2.2 IDO Inhibitors Revenue Share by Manufacturers (2014-2019)
3.3 IDO Inhibitors Price by Manufacturers
3.4 IDO Inhibitors Manufacturing Base Distribution, Product Types
3.4.1 IDO Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers IDO Inhibitors Product Type
3.4.3 Date of International Manufacturers Enter into IDO Inhibitors Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global IDO Inhibitors Sales by Product
4.2 Global IDO Inhibitors Revenue by Product
4.3 IDO Inhibitors Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global IDO Inhibitors Breakdown Data by End User
6 North America
6.1 North America IDO Inhibitors by Countries
6.1.1 North America IDO Inhibitors Sales by Countries
6.1.2 North America IDO Inhibitors Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America IDO Inhibitors by Product
6.3 North America IDO Inhibitors by End User
7 Europe
7.1 Europe IDO Inhibitors by Countries
7.1.1 Europe IDO Inhibitors Sales by Countries
7.1.2 Europe IDO Inhibitors Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe IDO Inhibitors by Product
7.3 Europe IDO Inhibitors by End User
8 Asia Pacific
8.1 Asia Pacific IDO Inhibitors by Countries
8.1.1 Asia Pacific IDO Inhibitors Sales by Countries
8.1.2 Asia Pacific IDO Inhibitors Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific IDO Inhibitors by Product
8.3 Asia Pacific IDO Inhibitors by End User
9 Central & South America
9.1 Central & South America IDO Inhibitors by Countries
9.1.1 Central & South America IDO Inhibitors Sales by Countries
9.1.2 Central & South America IDO Inhibitors Revenue by Countries
9.1.3 Brazil
9.2 Central & South America IDO Inhibitors by Product
9.3 Central & South America IDO Inhibitors by End User
10 Middle East and Africa
10.1 Middle East and Africa IDO Inhibitors by Countries
10.1.1 Middle East and Africa IDO Inhibitors Sales by Countries
10.1.2 Middle East and Africa IDO Inhibitors Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa IDO Inhibitors by Product
10.3 Middle East and Africa IDO Inhibitors by End User
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer IDO Inhibitors Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer IDO Inhibitors Products Offered
11.1.5 Pfizer Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Company Business Overview
11.2.3 Bristol-Myers Squibb IDO Inhibitors Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bristol-Myers Squibb IDO Inhibitors Products Offered
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Kyowa Hakko Kirin
11.3.1 Kyowa Hakko Kirin Company Details
11.3.2 Company Business Overview
11.3.3 Kyowa Hakko Kirin IDO Inhibitors Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Kyowa Hakko Kirin IDO Inhibitors Products Offered
11.3.5 Kyowa Hakko Kirin Recent Development
12 Future Forecast
12.1 IDO Inhibitors Market Forecast by Regions
12.1.1 Global IDO Inhibitors Sales Forecast by Regions 2019-2025
12.1.2 Global IDO Inhibitors Revenue Forecast by Regions 2019-2025
12.2 IDO Inhibitors Market Forecast by Product
12.2.1 Global IDO Inhibitors Sales Forecast by Product 2019-2025
12.2.2 Global IDO Inhibitors Revenue Forecast by Product 2019-2025
12.3 IDO Inhibitors Market Forecast by End User
12.4 North America IDO Inhibitors Forecast
12.5 Europe IDO Inhibitors Forecast
12.6 Asia Pacific IDO Inhibitors Forecast
12.7 Central & South America IDO Inhibitors Forecast
12.8 Middle East and Africa IDO Inhibitors Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 IDO Inhibitors Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure IDO Inhibitors Product Picture
Table IDO Inhibitors Market Segments
Table Key Manufacturers IDO Inhibitors Covered
Table Global IDO Inhibitors Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global IDO Inhibitors Sales Market Share by Product 2014-2025
Figure Dual IDO1/TDO inhibitors Product Picture
Table Major Manufacturers of Dual IDO1/TDO inhibitors
Figure Covalent IDO inhibitors Product Picture
Table Major Manufacturers of Covalent IDO inhibitors
Table Global IDO Inhibitors Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Metastatic Melanoma
Figure Metastatic Pancreatic Cancer
Figure mCRPC
Figure Malignant Glioma
Figure Astrocytoma
Figure Breast Cancer
Figure IDO Inhibitors Report Years Considered
Figure Global IDO Inhibitors Market Size 2014-2025 (Million US$)
Figure Global IDO Inhibitors Sales 2014-2025 (K Units)
Table Global IDO Inhibitors Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global IDO Inhibitors Sales by Regions 2014-2019 (K Units)
Table Global IDO Inhibitors Sales Market Share by Regions 2014-2019
Figure Global IDO Inhibitors Sales Market Share by Regions 2014-2019
Figure 2018 Global IDO Inhibitors Sales Market Share by Regions
Table Global IDO Inhibitors Revenue by Regions 2014-2019 (Million US$)
Table Global IDO Inhibitors Revenue Market Share by Regions 2014-2019
Figure Global IDO Inhibitors Revenue Market Share by Regions 2014-2019
Figure 2018 Global IDO Inhibitors Revenue Market Share by Regions
Table Global IDO Inhibitors Sales by Manufacturers (2014-2019) (K Units)
Table Global IDO Inhibitors Sales Share by Manufacturers (2014-2019)
Figure Global IDO Inhibitors Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table IDO Inhibitors Revenue by Manufacturers (2014-2019) (Million USD)
Table IDO Inhibitors Revenue Share by Manufacturers (2014-2019)
Figure IDO Inhibitors Value Share by Manufacturers in 2018
Table Key Manufacturers IDO Inhibitors Price (2014-2019) (USD/Unit)
Table IDO Inhibitors Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers IDO Inhibitors Product Type
Table Date of International Manufacturers Enter into IDO Inhibitors Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global IDO Inhibitors Sales by Product (2014-2019) (K Units)
Table Global IDO Inhibitors Sales Share by Product (2014-2019)
Figure Global IDO Inhibitors Sales Market Share by Product (2014-2019)
Figure Global IDO Inhibitors Sales Market Share by Product in 2018
Table Global IDO Inhibitors Revenue by Product (2014-2019) (Million US$)
Table Global IDO Inhibitors Revenue Share by Product (2014-2019)
Figure Global IDO Inhibitors Revenue Market Share by Product (2014-2019)
Figure Global IDO Inhibitors Revenue Market Share by Product in 2018
Table IDO Inhibitors Price by Product 2014-2019 (USD/Unit)
Table Global IDO Inhibitors Sales by End User (2014-2019) (K Units)
Table Global IDO Inhibitors Sales Share by End User (2014-2019)
Figure Global Sales IDO Inhibitors Market Share by End User (2014-2019)
Figure Global Sales IDO Inhibitors Market Share by End User in 2018
Figure North America IDO Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure North America IDO Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table North America IDO Inhibitors Sales by Countries (2014-2019) (K Units)
Table North America IDO Inhibitors Sales Market Share by Countries (2014-2019)
Figure 2018 North America IDO Inhibitors Sales Market Share by Countries
Table North America IDO Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table North America IDO Inhibitors Revenue Market Share by Countries (2014-2019)
Figure 2018 North America IDO Inhibitors Revenue Market Share by Countries
Figure United States IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure United States IDO Inhibitors Revenue Growth Rate (2014-2019) (K Units)
Figure Canada IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Canada IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Mexico IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Table North America IDO Inhibitors Sales by Product (2014-2019) (K Units)
Table North America IDO Inhibitors Sales Market Share by Product (2014-2019)
Figure 2018 North America IDO Inhibitors Market Share by Product
Table North America IDO Inhibitors Sales by End User (2014-2019) (K Units)
Table North America IDO Inhibitors Sales Market Share by End User (2014-2019)
Figure 2018 North America IDO Inhibitors Market Share by End User
Figure Europe IDO Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure Europe IDO Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Europe IDO Inhibitors Sales by Countries (2014-2019) (K Units)
Table Europe IDO Inhibitors Sales Market Share by Countries (2014-2019)
Figure 2018 Europe IDO Inhibitors Sales Market Share by Countries
Table Europe IDO Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Europe IDO Inhibitors Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe IDO Inhibitors Revenue Market Share by Countries
Figure Germany IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Germany IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure France IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure France IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure UK IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure UK IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Italy IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Russia IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Table Europe IDO Inhibitors Sales by Product (2014-2019) (K Units)
Table Europe IDO Inhibitors Sales Market Share by Product (2014-2019)
Figure 2018 Europe IDO Inhibitors Market Share by Product
Table Europe IDO Inhibitors Sales by End User (2014-2019) (K Units)
Table Europe IDO Inhibitors Sales Market Share by End User (2014-2019)
Figure 2018 Europe IDO Inhibitors Market Share by End User
Figure Asia Pacific IDO Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific IDO Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific IDO Inhibitors Sales by Countries (2014-2019) (K Units)
Table Asia Pacific IDO Inhibitors Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific IDO Inhibitors Sales Market Share by Countries
Table Asia Pacific IDO Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific IDO Inhibitors Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific IDO Inhibitors Revenue Market Share by Countries
Figure China IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure China IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Japan IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Korea IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure India IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure India IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Australia IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Philippines IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Thailand IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Singapore IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific IDO Inhibitors Sales by Product (2014-2019) (K Units)
Table Asia Pacific IDO Inhibitors Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific IDO Inhibitors Market Share by Product
Table Asia Pacific IDO Inhibitors Sales by End User (2014-2019) (K Units)
Table Asia Pacific IDO Inhibitors Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific IDO Inhibitors Market Share by End User
Figure Central & South America IDO Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America IDO Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America IDO Inhibitors Sales by Countries (2014-2019) (K Units)
Table Central & South America IDO Inhibitors Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America IDO Inhibitors Sales Market Share by Countries
Table Central & South America IDO Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Central & South America IDO Inhibitors Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America IDO Inhibitors Revenue Market Share by Countries
Figure Brazil IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Brazil IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Argentina IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America IDO Inhibitors Sales by Product (2014-2019) (K Units)
Table Central & South America IDO Inhibitors Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America IDO Inhibitors Market Share by Product
Table Central & South America IDO Inhibitors Sales by End User (2014-2019) (K Units)
Table Central & South America IDO Inhibitors Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America IDO Inhibitors Market Share by End User
Figure Middle East and Africa IDO Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa IDO Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa IDO Inhibitors Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa IDO Inhibitors Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa IDO Inhibitors Sales Market Share by Countries
Table Middle East and Africa IDO Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa IDO Inhibitors Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa IDO Inhibitors Revenue Market Share by Countries
Figure GCC Countries IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Turkey IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Egypt IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa IDO Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure South Africa IDO Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa IDO Inhibitors Sales by Product (2014-2019) (K Units)
Table Middle East and Africa IDO Inhibitors Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa IDO Inhibitors Market Share by Product
Table Middle East and Africa IDO Inhibitors Sales by End User (2014-2019) (K Units)
Table Middle East and Africa IDO Inhibitors Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa IDO Inhibitors Market Share by End User
Table Pfizer Company Details
Table Pfizer IDO Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb IDO Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Kyowa Hakko Kirin Company Details
Table Kyowa Hakko Kirin IDO Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Kyowa Hakko Kirin Recent Development
Table Global IDO Inhibitors Sales Forecast by Regions 2019-2025 (K Units)
Table Global IDO Inhibitors Sales Market Share Forecast by Regions 2019-2025
Table Global IDO Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global IDO Inhibitors Revenue Market Share Forecast by Regions 2019-2025
Table Global IDO Inhibitors Sales Forecast by Product 2019-2025 (K Units)
Table Global IDO Inhibitors Sales Market Share Forecast by Product 2019-2025
Table Global IDO Inhibitors Revenue Forecast by Product 2019-2025 (Million US$)
Table Global IDO Inhibitors Revenue Market Share Forecast by Product 2019-2025
Table Global IDO Inhibitors Sales Forecast by End User 2019-2025 (K Units)
Table Global IDO Inhibitors Sales Market Share Forecast by End User 2019-2025
Figure North America IDO Inhibitors Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America IDO Inhibitors Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe IDO Inhibitors Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe IDO Inhibitors Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific IDO Inhibitors Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific IDO Inhibitors Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America IDO Inhibitors Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America IDO Inhibitors Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa IDO Inhibitors Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa IDO Inhibitors Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table IDO Inhibitors Value Chain
Table IDO Inhibitors Customers List
Table IDO Inhibitors Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
mTOR阻害剤の世界市場：インサイト・予測 mTOR inhibitors are a class of drugs that inhibit the mechanistic target of rapamycin (mTOR).Mammalian target of rapamycin (mTOR) inhibitors block the activity of the mammalian target of rapamycin. Mammalian target of rapamycin is a protein kinase, which regulates growth factors that stimulate cell …- 免疫チェックポイント阻害剤の世界市場：市場規模・現状・予測 Check point inhibitors are molecules that use the cosmic potential of the immune response system of the body, and its limitless influences to attack the cancer cells present inside the body, as well as avoids relapse of cancer cells. In case any relapse occurs in the body, it can easily be recognize…
- TNF阻害剤の世界市場：市場規模・現状・予測 TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflamm…
- TNF阻害剤の世界市場：市場規模・現状・予測 TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflamm…
- 世界の未分化リンパ腫キナーゼ阻害剤市場：動向・競争分析 ALK inhibitors are potential anti-cancer drugs that act on tumours with variations of anaplastic lymphoma kinase (ALK) such as an EML4-ALK translocation.[In 2018, the global Anaplastic Lymphoma Kinase Inhibitors market size was xx million US$ and is forecast to xx million US in 2025, growing at a CA…